Literature DB >> 26798227

Immunoglobulin G4-Related Sclerosing Disease Manifesting as Bilateral Tonsillar Hypertrophy on MR Images: A Case Report.

Mee Hyun Park1, Ji Young Woo1, Yul Lee1, Dae Young Yoon2, Hye Sook Hong1, Min Eui Hong3.   

Abstract

Immunoglobulin G4-related sclerosing disease (IgG4-SD) is currently recognized as a distinct systemic disease involving various organs. We reported the imaging findings of a case of pathologically confirmed IgG4-SD involving bilateral palatine tonsils. CT and MRI showed diffuse enlargement of both palatine tonsils with homogeneous contrast enhancement. Focal contour bulging was noted in the right palatine tonsil. Lesions appeared as isointense on T1-weighted and slightly hyperintense on T2-weighted MRI images, as compared with muscle. The T2-weighted MRI image showed a striated pattern in both tonsils. Despite its rare occurrence, IgG4-SD should be included in the differential diagnoses of patients with symptomatic bilateral tonsillar hypertrophy that is non-responsive to medication.

Entities:  

Keywords:  IgG4-related sclerosing disease; MRI; Palatine tonsil

Mesh:

Substances:

Year:  2016        PMID: 26798227      PMCID: PMC4720802          DOI: 10.3348/kjr.2016.17.1.147

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  11 in total

1.  Radiological features of IgG4-related disease in the head, neck, and brain.

Authors:  Masaki Katsura; Harushi Mori; Akira Kunimatsu; Hiroki Sasaki; Osamu Abe; Toru Machida; Kuni Ohtomo
Journal:  Neuroradiology       Date:  2012-02-23       Impact factor: 2.804

2.  Giant Hepatic Artery Aneurysm Associated with Immunoglobulin G4-Related Disease Successfully Treated Using a Liquid Embolic Agent.

Authors:  Michele Rossi; Edoardo Virgilio; Florindo Laurino; Gianluigi Orgera; Paolo Menè; Nicola Pirozzi; Vincenzo Ziparo; Marco Cavallini
Journal:  Korean J Radiol       Date:  2015-07-01       Impact factor: 3.500

3.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 4.  IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations.

Authors:  Paraskevi A Vlachou; Korosh Khalili; Hyun-Jung Jang; Sandra Fischer; Gideon M Hirschfield; Tae Kyoung Kim
Journal:  Radiographics       Date:  2011 Sep-Oct       Impact factor: 5.333

5.  IgG4-related sclerosing disease clinically mimicking oral squamous cell carcinoma.

Authors:  Syed Ali Khurram; Malee Fernando; Austen T Smith; Keith D Hunter
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-08-15

6.  An immunoglobulin G4-related sclerosing disease of the small bowel: CT and small bowel series findings.

Authors:  Younghwan Ko; Ji Young Woo; Jeong Won Kim; Hye Sook Hong; Ik Yang; Yul Lee; Daehyun Hwang; Seon Jeong Min
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

Review 7.  IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

8.  Small bowel obstruction caused by peritoneal immunoglobulin g4-related disease mimicking carcinomatosis: case report.

Authors:  Bruno Coulier; Luc Montfort; Gabriela Beniuga; Frederic Pierard; Isabelle Gielen
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

9.  Immunoglobulin G4-related sclerosing disease involving the urethra: case report.

Authors:  Jin Woo Choi; Sang Youn Kim; Kyung Chul Moon; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

10.  A new clinicopathological entity of IgG4-related autoimmune disease.

Authors:  Terumi Kamisawa; Nobuaki Funata; Yukiko Hayashi; Yoshinobu Eishi; Morio Koike; Kouji Tsuruta; Atsutake Okamoto; Naoto Egawa; Hitoshi Nakajima
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.